Results of investigation: it was reported that, 10 years after a left total hip replacement surgery, the patient experienced luxation.This adverse event was treated with a closed reposition procedure.Current health status of patient is unknown.Due to the nature of the reported incident, the device used in treatment was not returned for investigation.A product evaluation was not possible.No batch number was communicated so the production history review was not possible.Due to insufficient information it is not possible to perform a review of past corrective actions.Due to limited information, it is not possible to conduct a review of historical complaints.Nevertheless, the current complaint is aligned with the conclusion of the corresponding post market surveillance report.A review of the risk management documentation verifies the failure mode, occurrence and severity of the reported issue.Insufficient information was made available to determine the revision of the instructions for use applicable to the device at the time of manufacturing.However, a review of the current revision was conducted and it revealed that the instructions for use (lit.No.12.23, ed.03/21) states joint dislocation as a ¿potential adverse device effect¿ in combination with the implantation of a hip prosthesis.No clinically sufficient data was provided to perform a medical investigation.The performed investigation does not lead to an accurately determined cause.Based on the available information it is not possible to investigate whether the reported device met manufacturing specifications upon release for distribution.Due to insufficient information, it is not possible to indicate factors which could have contributed to the reported event.There is no need for further actions because of the limited information provided.Nevertheless, smith + nephew will continue to monitor this device for similar issues.This complaint will be reopened should additional information or the device be received.Corrected data: d3(manufacturer us state not applicable), g1 (contact office - manufacturing site: "tennessee" not applicable), h6 (health effect - clinical code).
|